1 option
Turmeric and curcumin for neurodegenerative disease / Magisetty Obulesu.
- Format:
- Book
- Author/Creator:
- Obulesu, Magisetty.
- Language:
- English
- Subjects (All):
- Nervous system--Degeneration--Chemotherapy.
- Nervous system.
- Turmeric--Therapeutic use.
- Turmeric.
- Curcumin--Therapeutic use.
- Curcumin.
- Nanomedicine.
- Nervous system--Degeneration.
- Chemotherapy.
- Genre:
- Electronic books.
- Physical Description:
- 1 online resource
- Place of Publication:
- [Place of publication not identified] : Academic Press, 2021.
- System Details:
- text file
- Contents:
- Part 1 Alzheimer's disease
- 1 Health benefits of turmeric: Emphasis on anticancer activity p. 3
- Gun puffing p. 4
- Curcumin p. 4
- Anticancer efficacy of curcumin p. 5
- Colorectal cancer p. 5
- Renal, bone, and lung cancer p. 6
- Blood and other cancers p. 6
- Antioxidant and antiinflammatory activity p. 7
- Noncurcuminoids p. 9
- Turmerones p. 10
- Elemenes p. 10
- ß-Elemene p. 11
- Furanodiene, furanodienone, curcumol, and calebin A p. 11
- Conclusions and future perspectives p. 13
- 2 Turmeric products in Alzheimer's disease p. 19
- Natural compounds p. 20
- Curcumin p. 20
- Volatile essential oils of curcumin p. 21
- Studies on human subjects p. 22
- Metal-chelation by curcumin p. 22
- Antiamyloidogenic activity p. 22
- Signaling p. 23
- Curcumin analogs p. 24
- Theracurmin p. 25
- Shortcomings in therapeutic efficacy of curcumin p. 25
- Conclusions and future perspectives p. 27
- 3 Curcumin in Alzheimer's disease diagnosis and treatment p. 35
- Curcumin's influence on enzymes p. 37
- Curcumin and resveratrol p. 37
- Oxidative damage p. 39
- Chemistry and metabolism p. 40
- Inflammation p. 40
- Curcumin in Alzheimer's disease diagnosis p. 40
- Studies on humans p. 42
- Amyloid interaction p. 42
- Conclusions and future perspectives p. 43
- 4 Curcumin loaded drug delivery systems in the treatment of Alzheimer's disease p. 51
- Curcumin p. 52
- Tau inhibition p. 52
- Challenges p. 53
- Curcumin delivery systems p. 53
- Polymeric nanoparticles p. 54
- Poly(lactic-co-glycolic acid) p. 54
- Surface modification p. 57
- Chitosan p. 58
- Micelles p. 59
- Phytosomes p. 59
- Lipid-based nanocarriers p. 60
- Liposomes p. 61
- Liquid crystalline nanocarriers p. 62
- Solid lipid nanoparticles p. 62
- Nanostructured lipid carriers p. 63
- Magnetic nanoparticles p. 63
- Theranostic approach of curcumin p. 64
- Conclusions and future perspectives p. 64
- Part 2 Parkinson's disease
- 5 Turmeric products in Parkinson's disease treatment p. 73
- α-Synuclein p. 74
- Therapeutics p. 74
- Turmeric p. 75
- Turmerone p. 75
- Furanodiene p. 76
- Curcumin p. 76
- α-Synudein p. 76
- Antioxidant activity p. 79
- Curcumin against inflammation p. 79
- Neuronal apoptosis p. 80
- Curcumin analogs p. 80
- Conclusions and future perspectives p. 81
- 6 Curcumin in Parkinson's disease treatment p. 89
- Drugs p. 90
- Polyphenols p. 90
- α-Synuclein p. 91
- Curcumin p. 92
- Autophagy in Parkinson's disease p. 94
- Curcumin analogs p. 94
- Cyclocurcumin p. 95
- Tetrahydrocurcumin p. 96
- CNB-001 p. 97
- Conclusions and future perspectives p. 98
- 7 Curcumin loaded drug delivery systems in Parkinson's disease p. 105
- Blood-brain barrier p. 105
- Curcumin p. 105
- Challenges in curcumin's therapeutic efficacy p. 107
- Drug delivery systems p. 107
- Nanoformulations of curcumin p. 108
- Polymeric nanoparticles p. 110
- Micelles p. 110
- Liposomes p. 111
- Solid lipid nanoparticles p. 112
- Surface functionalization p. 112
- Conclusions and future perspectives p. 112
- Part 3 Liver diseases
- 8 Turmeric products in liver disease treatment p. 123
- Nonalcoholic fatty liver disease p. 124
- Oxidative stress in liver diseases p. 125
- Drugs p. 125
- Natural products p. 126
- Turmeric p. 126
- Composition p. 126
- Therapeutic efficacy of turmeric p. 127
- Clinical trials p. 128
- Turmeric products p. 129
- Curcumin p. 129
- Oxidative liver damage p. 130
- Elemene p. 131
- Conclusions and future perspectives p. 132
- 9 Curcumin in liver disease treatment p. 139
- Drugs and liver p. 140
- Curcumin p. 141
- Curcumin counters liver damage p. 142
- Protective efficacy of curcumin against liver-fibrosis and cirrhosis p. 143
- Liver cirrhosis p. 144
- Role of curcumin in nonalcoholic steatohepatitis p. 145
- Role of curcumin In alcoholic liver disease p. 145
- Role of curcumin against oxidative liver damage p. 145
- Animal models p. 147
- Conclusions and future perspectives p. 148
- 10 Curcumin loaded drug delivery systems in the treatment of liver diseases p. 155
- Challenges in curcumin's therapeutic efficacy and strategies to overcome p. 156
- Drug delivery systems p. 158
- Cancer p. 159
- Hepatic fibrosis p. 161
- Nanoparticles targeted against liver inflammation p. 162
- Conclusions and future perspectives p. 163.
- Notes:
- Includes index.
- ISBN:
- 9780128224496
- 0128224495
- OCLC:
- 1233252714
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.